BoneDisease.gif Back grey_arrow_rt.gif
 
Recent articles on bone issues.
 
null.gif
 
 
  1. FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures - (03/12/10)
     
  2. Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs May Affect Quality and Structural Integrity of Bone - (03/12/10)
     
  3. Long-term use of bisphosphonates may increase risk of atypical fractures: studies - (03/12/10)
     
  4. CROI: Longitudinal Analysis of Bone Mineral Density in Aging Men With or at Risk for HIV Infection: heroin causes bone loss; accelerated bone loss progressed over 3 years in HIV+ - (03/10/10)
     
  5. CROI: Changes in Bone Mineral Density: two-years follow-up of the ANRS CO3 Aquitaine Cohort - Bone Metabolism Evolves- in 11% from osteopenia to osteoporosis and to osteopenia, bone markers worsen in 41% - (03/10/10)
     
  6. CROI: Bone & Limb Fat Outcomes in ACTG5202- More Bone Loss With TDF/FTC Than ABC/3TC - written by Mark Mascolini - (02/23/10)
     
  7. CROI:Bone Fractures at CROI 2010 - see slides below - (02/23/10)
     
  8. CROI: Bone Disease: Risk Factors - (02/22/10)
     
  9. Bone Loss in HIV+ Premenopausal Women & Fracture Risk - (02/04/10)
     
  10. Visceral Fat Causes Inflammation and Cytokines Leading To Bone Loss - (01/16/09)
     
  11. HIV-Infected Postmenopausal Women at High Risk for Bone Fractures - pdf publication attached - (01/11/09)
     
  12. Exploring a Low-Acid Diet for Bone Health - (11/25/09)
     
  13. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial - (10/04/09)
     
  14. Fall Prevention: how much vitamin D do you need? - (10/04/09)
     
  15. Vitamin D Improves Muscle Function - (09/29/09)
     
  16. Sex Steroids & Fracture Risk in Men - (09/06/09)
     
  17. Lipodystrophy & Bone Loss - (09/06/09)
     
  18. Vitamin D, Diabetes & Bone in African-Americans - (09/06/09)
     
  19. A Potential Role for Vitamin D on HIV Infection? - (09/03/09)
     
  20. Vitamin D Immunomodulator EDITORIAL - (09/03/09)
     
  21. Low Vitamin D Levels Increased Risk for HIV MTCT: Perinatal Outcomes, Including Mother-to-Child Transmission of HIV, and Child Mortality and Their Association with Maternal Vitamin D Status in Tanzania - (09/03/09)
     
  22. Oxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss - pdf attached - (08/27/09)
     
  23. The clot thickens-oxidized lipids and thrombosis - (08/26/09)
     
  24. Oxidized lipids: a key to heart disease? - (08/26/09)
     
  25. Aging/HIV Clinical Care & Research - New IDSA Guidelines - (08/26/09)
     
  26. Thyroid Dysfunction, Hypogonadism, Testosterone, Bone, Prostate Cancer, HIV & HAART - (08/26/09)
     
  27. Aging & HIV Recognized as a Serious Concern But No Real Discussion, Still Ignored. 2007 NIH Workshop recommendations - (08/26/09)
     
  28. A serum 25-hydroxyvitamin D level below 50 nmol/l has been associated with increased body sway and a level below 30 nmol/l with decreased muscle strength. - (08/18/09)
     
  29. Vitamin D deficiency, muscle function, and falls in elderly people1,2 Review Article - (08/18/09)
     
  30. Thiazolidinediones and Fractures in Men and Women - (08/12/09)
     
  31. Bone Guidelines Excerpted From New IDSA Guidelines- pdf of full paper attached  - (08/12/09)
     
  32. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004 - pdf of published report attached - (08/12/09)
     
  33. Bone mineral density and disorders of mineral metabolism in chronic liver disease: Cirrhotics Have Low Bone Density & Low Vitamin D Levels - (08/04/09)
     
  34. -2.5% Bone Loss Over 96 Weeks on PI or NNRTI in study reported - (08/04/09)
     
  35. 5th IAS: Highly prevalent vitamin D deficiency and insufficiency among an urban cohort of human immunodeficiency virus (HIV)-infected men under care - (07/28/09)
     
  36. 5th IAS: ARTs Cause Bone Loss - (07/28/09)
     
  37. 5th IAS: Long-Term Bone Loss Similar With PI- and NRTI-Sparing Regimens - written by Mark Mascolini - (07/21/09)
     
  38. 5th IAS: European Researchers Issuing Guidelines on Bone Disease - (07/19/09)
     
  39. Metabolic bone disease in HIV infection: HIV, ART Implicated EDITORIAL - (07/02/09)
     
  40. First line AZT/3TC/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir - (07/02/09)
     
  41. Monitoring bone mineral density during antiresorptive treatment for osteoporosis - Editorial - (06/27/09)
     
  42. Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data - (06/27/09)
     
  43. The Value of Bone Density Testing - (06/27/09)
     
  44. FDA Approves Zoledronic Acid - Reclast(R) - to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing, Once Every 2 Years - (06/03/09)
     
  45. Efavirenz and bone health - (05/22/09)
     
  46. Sunlight and Vitamin D Both Good for Cardiovascular Health - (04/22/09)
     
  47. Glucocorticoid-induced osteoporosis: hope on the HORIZON-COMMENT - (04/20/09)
     
  48. HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty: HIV+ men in MACS 10-Times More Likely to Exhibit Frailty than HIV-negative Men. - (04/20/09)
     
  49. MACS Frailty/HIV/CD4 Study Misses The Point - (04/20/09)
     
  50. Osteoporosis Drug Teriparatide Speeds Fracture Healing - (04/20/09)
     
  51. Vitamin D Deficiency in Older Men - (04/09/09)
     
  52. Relationships of Serum 25-Hydroxyvitamin D to Bone Mineral Density and Serum Parathyroid Hormone and Markers of Bone Turnover in Older Persons - (04/09/09)
     
  53. CROI: Osteopenia and Osteoporosis in HIV-infected Patients Are Associated with Reduced Frequency of Central Memory CD8+CD127+ T Cells: T-cell activation/senescence associated with bone loss - (03/05/09)
     
  54. CROI: HIV-1 Induces Apoptosis in primary Osteoblasts: an Alternative Mechanism in the Osteopenia/Osteoporosis Development - (03/04/09)
     
  55. CROI: GENDER AND GONADAL FUNCTION DIFFERENCES IN THE PREVALENCE OF BONE MASS REDUCTION: higher rates of osteopenia and osteoporosis for men vs women and at early ages, in their 40s. - (03/04/09)
     
  56. CROI: Bone/Osteoporosis CROI 2009 Update - written by Todd Brown, MD, PhD (03/04/09)
     
  57. CROI: Immune Senescence, Activation and Abnormal T cell Homeostasis Despite Effective HAART, A Hallmark of Early Aging in HIV Disease - (03/03/09)
     
  58. CROI: Changes in Bone Turnover, OPG/RANKL, and Inflammation with ART Initiation: A Comparison of Tenofovir- and Non-Tenofovir-Containing Regimens - (03/03/09)
     
  59. CROI: Evaluation of peripheral DEXA Bone Densitometry to identify low bone mineral density in HIV- infected men in UK: 60% osteopenia, 13% osteoporosis- median age 41 yrs; t-score/dexa predicts fracture in HIV - (03/03/09)
     
  60. CROI: Clinical Determinants of Bone Mineral Density (BMD) in Perinatally HIV-Infected Children - (03/03/09)
     
  61. CROI: Bone Mineral Density in HIV+ Women: Relationship to Body Composition - (03/03/09)
     
  62. CROI: Preferential Bone Demineralization at the Hip in Treated HIV+ Males: Another Example of Premature Aging? - (03/03/09)
     
  63. CROI: Determinants (HIV, Cytokines) of Low Bone Density in Postmenopausal HIV+ Women - (03/03/09)
     
  64. CROI: Short term bone loss in HIV infected premenopausal women - (03/03/09)
     
  65. CROI: Bone Loss at Baseline and Week 144 in Study 903 TDF vs d4T + EFV (02/23/09)
     
  66. Vitamin D's Expanding Role EDITORIAL - (02/07/09)
     
  67. Vitamin D Status and Muscle Function in Post-Menarchal Adolescent Girls - (02/07/09)
     
  68. Patient Information Page from The Hormone Foundation: Vitamin D, Calcium, and Bone Health - (02/06/09)
     
  69. Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women - (02/05/09)
     
  70. High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients - (02/03/09)
     
  71. Vitamin D Deficiency in Older Men - (01/30/09)
     
  72. Annual Zoledronate Increases Bone Density in Highly Active Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Men: A Randomized Controlled Trial - (12/30/08)
     
  73. Once A Year Zoledronate Bone Therapy Increased Bone Density & T-Scores - (12/30/08)
     
  74. Thyroid Dysfunction & Bone Disease in HIV & HCV; Thyroid Testing Recommended by UK Group - (12/30/08)
     
  75. DART: Foot-Fractures in HIV+ Men Written for NATAP by Mark Mascolini - (12/11/08)
     
  76. The cell biology of bone metabolism - (12/09/08)
     
  77. Bone Finding May Point to Hope for Osteoporosis - (12/02/08)
     
  78. 9th Interntl Drug Thrpy HIV: High HIV Load Stymies Calcium Deposition in Bone-Forming Cells - Written by Mark Mascolini - (11/12/08)
     
  79. 2 New Osteoporosis Drugs in the Works: Biologic Osteoporosis Drugs Denosumab and Odanacatib Show Promise in Clinical Trials - (09/22/08)
     
  80. Update in Osteoporosis and Metabolic Bone Disorders - (09/22/08)
     
  81. Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate - (09/22/08)
     
  82. Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Increased BMD Over Two Years at Key Fracture Sites in Phase IIB Study - (09/22/08)
     
  83. Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women: phase 3 results - (09/22/08)
     
    84. v
  84. Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians - (09/18/08)
     
  85. (Increased) Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study - (09/17/08)
     
  86. Risk factors for decreased bone density and effects of HIV on bone in the elderly - (09/3/08)
     
  87. The near absence of osteoporosis treatment in older men with fractures - (09/3/08)
     
  88. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection [EPIDEMIOLOGY AND SOCIAL] - (09/3/08)
     
  89. HIV Infection and Bone Mineral Density in Middle-Aged Women - (09/3/08)
     
  90. Bone and Mineral Metabolism in Human Immunodeficiency Virus Infection - (09/2/08)
     
  91. Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study - (09/2/08)
     
  92. Long-term use of bisphosphonates in the treatment of HIV-related bone pain in perinatally infected pediatric patients [Correspondence] - (08/29/08)
     
  93. FRAX Bone Treatment Algorithm: A Revised Clinician's Guide to the Prevention and Treatment of Osteoporosis- commentary - (07/15/08)
     
  94. Serial Assessment of Serum Bone Metabolism Markers Identifies Women with the Highest Rate of Bone Loss and Osteoporosis Risk - (07/15/08)
     
  95. CLINICIAN'S GUIDE TO PREVENTION AND TREATMENT OF OSTEOPOROSIS (National Osteoporosis Foundation Guidelines) - (07/07/08)
     
  96. Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture - (07/04/08)
     
  97. Use of Antidepressants and Rates of Hip Bone Loss in Older Women - (07/04/08)
     
  98. Fracture Prevalence Among HIV-Infected versus Non HIV-Infected Patients in a Large U.S. Healthcare System - (07/02/08)
     
  99. Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial - (05/22/08)
     
  100. Guidelines Recommend Screening for Men at Increased Risk for Ostoeporosis. - (05/10/08)
     
  101. Comparative Efficacy between therapies for bone disease: What We Know, What We Need to Know, and How We Can Get There EDITORIAL - (05/10/08)
     
  102. Guidelines Recommend Screening for Men at Increased Risk for Ostoeporosis. "Screening for Osteoporosis in Men: A Clinical Practice Guideline from the American College of Physicians" - (05/10/08)
     
  103. Bone health & Antiepileptic Drugs - (05/02/08)
     
  104. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy - (05/02/08)
     
  105. Use of Alendronate and Risk of Incident Atrial Fibrillation in Women - (05/01/08)
     
  106. Diabetes drugs (glitazones) double fracture risk: Swiss study - (05/01/08)
     
  107. Gut (liver), inflammation and osteoporosis: basic and clinical concepts - (04/16/08)
     
  108. Osteoporosis in Men - (04/07/08)
     
  109. Bone Disease in HIV: study finds, heavily pre-treated patients had Vitamin D deficiency & serum marker abnormalities & perhaps serum markers may be better for assessing patient risk than total BMD by DEXA - (04/03/08)
     
  110. Osteoporosis and Fractures Missing the Bridge? Commentary - (03/28/08)
     
  111. Do n-3 fatty acids prevent osteoporosis? - (03/26/07)
     
  112. Glitazones May Improve Endothelial Function & Weaken Bones At Once - (03/25/08)
     
  113. Two Genetic Variants Found to be Associated with Increased Risk for Osteoporosis and Fracture - (03/25/08)
     
  114. CROI: Bone Disease Is Increased in HIV; Cancer Risk Increases with Age & Immune Deficiency - (03/25/08)
     
  115. Randomized Trial of Once-Weekly PTH(1-84) on Bone Mineral Density and Remodeling - (03/20/08)
     
  116. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection - (03/20/07)
     
  117. Effects of Alendronate on BMD and Fracture Risk: The FOSIT Study - (03/17/08)
     
  118. Osteopenia: intervention & therapy - (03/17/08)
     
  119. Ten Years' Experience with Alendronate (5, 10 and 20 mg daily) for Osteoporosis in Postmenopausal Women - (03/17/08)
     
  120. OSTEOPENIA IN HIV: tests and markers to evaluate bone loss - (03/14/08)
     
  121. Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws - (03/14/08)
     
  122. Smoking Increases Bone Loss and Decreases Intestinal Calcium Absorption - (03/14/08)
     
  123. Clinical Use of Serum and Urine Bone Markers in the Management of Osteoporosis - (03/14/08)
     
  124. 10 vs 5 Years of Bisphosphonate Treatment for Postmenopausal Osteoporosis EDITORIAL - (03/14/08)
     
  125. The attainment of peak bone mass: what is the relationship between muscle growth and bone growth? - (03/13/08)
     
  126. Osteoporosis and chronic kidney disease - (03/13/08)
     
  127. Bone disorders in chronic liver disease - (03/10/08)
     
  128. Thiazolidinediones: New Evidence of Bone Loss Editorial - (03/03/08)
     
  129. Thiazolidinedione Treatment Decreases Bone Mineral Density in Type 2 Diabetic Men - (03/03/08)
     
  130. AZT Enhances Osteoclastogenesis and Bone Loss - (03/03/08)
     
  131. CROI: Bone Mineral Density (BMD) 96 Weeks after Antiretroviral Therapy (ART) Initiation: A Randomized Trial Comparing Efavirenz (EFV)-Based Therapy to a Lopinavir/ritonavir (LPV/r)-Containing Regimen with Simplification to LPV/r Monotherapy - (02/27/08)
     
  132. Thiazolidinedione Treatment Decreases Bone Mineral Density in Type 2 Diabetic Men - (02/22/08)
     
  133. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C - (02/22/08)
     
  134. CROI: Risk Factors for Reduced Bone Mineral Density In HIV-Infected Individuals In The Modern HAART Era - (02/22/08)
     
  135. CROI: Bone Metabolism in HIV: CROI 2008 Update - written by Todd T. Brown, MD, PhD - (02/22/08)
     
  136. Benefits of 2 Years of Intense Exercise on Bone Density, Physical Fitness, and Blood Lipids in Early Postmenopausal Osteopenic Women - (02/01/08)
     
  137. New Bone Drug Denosumab in Postmenopausal Women with Low Bone Mineral Density - (01/29/08)
     
  138. Low Serum Testosterone Caused Fractures, study found - (01/29/08)
     
  139. Bone Health: calcium, vitamin D - (01/29/08)
     
  140. Use of Oral Bisphosphonates and the Risk of Aseptic Osteonecrosis: A Nested Case-Control Study - (01/29/08)
     
  141. Serum 25-Hydroxyvitamin D and Bone Mineral Density in a Racially and Ethnically Diverse Group of Men - (01/29/08)
     
  142. Muscle mass and bone mineral indices: does the normalized bone mineral content differ with age? - (01/29/08)
     
  143. Vitamin D Reduces Risk of Fall by 23% - (01/29/08)
     
  144. Vitamin D: What's Enough? Part II - (01/29/08)
     
  145. From muscle strength to immunity, scientists find new vitamin D benefits Part 1 - (01/29/08)
     
  146. Increased Bone Turnover in Patients with Hypercholesterolemia. - (01/29/08)
     
  147. Muscle mass and bone mineral indices: does the normalized bone mineral content differ with age? - (01/29/08)
     
  148. New Bone Therapy Denosumab vs Fosamax - (01/25/08)
     
  149. Bone Loss 62% in HIV+ - (01/23/08)
     
  150. Factors Associated with Low Bone Mineral Density (BMD) in a Large Cohort of HIV-Infected U.S. Adults - Baseline Results from the SUN Study -CROI 2007 - (01/23/08)
     
  151. 80% Bone Abnormalities in France Aquitane Cohort, 27% Osteoporosis - (01/23/08)
     
  152. Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial - (01/04/08)
     
  153. Oral Bispohosphonates (Fosomax) Found To protect Against Osteonecrosis of Jaw in Osteoporosis - (01/04/08)
     
  154. Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial - (01/04/08)
     
  155. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV - (11/26/07)
     
  156. Effects of Continuing or Stopping Alendronate After 5 Years of Treatment - (01/03/07)
     
  157. Bone Disease in HIV: study finds, heavily pre-treated patients had Vitamin D deficiency & serum marker abnormalities & perhaps serum markers may be better for assessing patient risk than total BMD by DEXA - (05/31/05)
     
  158. BMD in Older Women Predicts Vertebral Fractures; vertebral fractures reduced survival; a single measure of BMD predicted vertebral factures - (12/18/07)
     
  159. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women - (11/07/05)
     
  160. Alendronate, Vitamin D, and Calcium for the Treatment of Osteopenia/Osteoporosis Associated With HIV Infection - (03/21/05)
     
  161. Bone Loss in Liver Disease
    162. (02/04/02)
     
  162. Bone Density and HIV Infection David Alain Wohl, MD University of North Carolina AIDS Treatment and Research Unit - April 3, 2002

    163.  
  163. Bone Abnormalities at ICAAC: Osteoporosis, Osteonecrosis Written for NATAP by Michael Norton, PA-C, Boriken Health Clinic, NYC - Jan 10, 2002

    164.  
  164. Low-impact exercise can increase bone mass in women
    165. - (10/31/01)
     
  165. Nucleosides (NRTIs) and Reduced Bone Mineral Density (Osteopenia) - (5/28/2001)
     
  166. Review of Studies on Bone Problems at ICAAC and Lipodystrophy Workshop
    - (9/22/00)
     
  167. Osteopenia in HIV Infection
    (01/05/00)